PharmaTalkRadio

PharmaTalkRadio

Download on the App Store

PharmaTalkRadio episodes

  • What is the State of Clinical Trial Patient Matching Right Now?
    About this podcast:
    Recorded at the 2025 DPHARM conference, this state of the union panel convenes site, technology and pharma to discuss: 
    • Different models and the pros and cons of the deployment models
    • What makes a great patient matching solution
    • Predicting what the future growth of this segment looks like
    • The role of AI in this space
    41 min
  • Balancing Innovation and Practicality in Immuno-Oncology Dose Selection
    About this podcast: 
    Recorded at the 2025 IO360º Summit, this podcast addresses how Project Optimus is reshaping dose selection from maximum tolerated dose to a balance of efficacy and safety. More specifically, this panel addresses FDA objectives for multi-dose selection, alternative dose-selection strategies with imaging, biomarkers and tumor burden analysis, the higher costs and longer timelines, and financial impacts for early-phase oncology companies. 

    For more information, go to IO360summit.com.
    46 min
  • Leveraging Local HCPs to Decentralize Clinical Research in North Carolina
    About this podcast: 
    Recorded at the 2025 CRAACO meeting, UNC Lineberger’s Comprehensive Cancer Center shares  an initiative to allow local HCPs to still provide clinical care to patients but decentralized research elements to the university system, following the FDA’s change in guidance on Form FDA 1572, which stopped requiring local healthcare professionals (HCPs) involved in DCTs to be listed if they’re only performing standard-of-care. 


    Dr J Kaitlin Morrison talks about the process from an initial pilot of two sites to more than 23 today, providing cancer patients across the state the opportunity to access clinical trials. Specifically:
    • How they are managing relationships with sites
    • How they’re monitoring research elements
    • Goals, next steps and thoughts for industry sponsors
    21 min
  • The Role of the CMO in BD and M&A Partnering with Pharma
    In this podcast, featuring a panel discussion from the 2025 Chief Medical Officer Summit 360°, CMOs with recent M&A and partnership experience share those experiences as well as how CMOs of other small to midsize emerging biotech companies can support the conversations and operations that take place throughout the process of business development. Specifically:
    • Different kinds of BD deals to be aware of
    • How the CMO fits into various phases of transactions
    • Appreciating how different c-suite colleagues and direct reports experience these transactions
    • The different pharma teams CMOs will interact with
    • What happens after the acquisition
    To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.
    28 min
  • Advances in Payload Delivery and Drug Conjugation
    In this panel discussion from the 2025 PODD: Partnership Opportunities in Drug Delivery Conference, pharma executives and drug delivery experts discuss conjugation and bioconjugation approaches to make ASOs and small molecules more tolerable while improving targeting. Technologies discussed include ADCs, PDCs, SMDCs, VDCs, RDCs and AOCs. Specifically they address:
    • Biological and chemical challenges for these therapies
    • Building out scalable manufacturing and a regulatory strategy
    • Hurdles to overcome to get products to market
    To learn more about the PODD Conference, please visit Drug-Delivery.org.
    30 min
  • Building Up a CMO Team as Your Company Evolves
    This podcast features a panel discussion from the 2025 Chief Medical Officer Summit 360° about how to strategically approach hiring FTEs, insourcing, outsourcing and contracting to be appropriately prepared for the different stages of a biotech companies development from preclinical to early stage to late stage trials to commercialization. Specifically:
    • Balancing the mix of hires and outsourcing
    • Hiring for skillsets to enable efficiency without overhiring
    • Reactive vs proactive hiring
    • Building in a stage appropriate way but also hiring in time for later stages
    To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.
    33 min
  • Beyond LNPs: Delivering Genetic Medicines with Novel Vehicles
    While lipid nanoparticles are the most clinically advanced drug delivery system for nucleic acid therapeutics, they are only one tool in a toolbox of potential delivery vehicles.

    In this panel discussion from the 2025 PODD: Partnership Opportunities in Drug Delivery Conference, pharma executives and drug delivery experts discuss additional tools, including polymeric nanoparticles, protein-based nanoparticles and extracellular vesicles with a focus on:
    • Where LNPs potentially fall short
    • Where different tools can enable therapeutic delivery
    • Challenges to achieving meaningful clinical impact for these different vehicles
    • Building out a portfolio of delivery vehicles

    To learn more about the PODD Conference, please visit Drug-Delivery.org.
    30 min
  • Pfizer on Advancing Data Analysis Capabilities through A New EDC/CDMS Platform
    About this podcast: 
    This podcast comes from the DPHARM 2025 meeting. Pfizer details how they jointly co-designed and implemented an EDC/CDMS platform that’s fit for purpose, and analysis data set. This session focuses on:
    • Engaging all stakeholders in designing the platform
    • The evolution of the platform focus: the transition from the majority of data coming from EDC to 3/4 of the data from third party sources
    • Impact of the advanced data analysis capabilities for risk management
    • Review of impact on initial studies now using the platform 
    For more information, go to DPHARMconference.com. 
    16 min

About PharmaTalkRadio

From the publisher's feed

PharmaTalkRadio is an internet radio podcast platform organized and supported by the Conference Forum to give easy and free access to industry professionals, patient advocacy and students in medicine…